Pharmacological therapy remains central in ASCVD management. Statinsalong with ezetimibe, bempedoic acid and PCSK9 inhibitorscontinue to drive effective LDL cholesterol reduction and cardiovascular risk prevention. Growing focus is now on residual Modulatory effects of BPC 157 on vasomotor tone and the activation of Src Caveolin 1 endothelial nitric oxide synthase pathway Scientific Reports BPC 157 Mark Hyman, MD What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B